Back to Search
JAMES COX, PHARMD
PHARMD
Pharmacist
NPI: 1912572702Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
E09954(MS)
Research & Publications (20)
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
PMID 19515503·Int J Radiat Oncol Biol Phys·2010
8-other
Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
PMID 19540055·Int J Radiat Oncol Biol Phys·2010
3-trial
Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
PMID 19660879·Int J Radiat Oncol Biol Phys·2010
4-observational
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
PMID 19577865·Int J Radiat Oncol Biol Phys·2010
3-trial
History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results.
PMID 19651367·J Clin Virol·2009
6-review
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
PMID 19632716·Lancet·2009
3-trial
Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.
PMID 19654066·Vaccine·2009
7-preclinical
Questionnaire survey on Canine Leishmaniosis in southeastern Spain.
PMID 19608347·Vet Parasitol·2009
7-preclinical
The effects of technological developments on nuclear medicine technologist productivity: a systematic review.
PMID 19619358·Int J Technol Assess Health Care·2009
1-meta
Post-translational modification and stability of low molecular weight cyclin E.
PMID 19561641·Oncogene·2009
8-other
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
PMID 19571599·Oncology·2009
8-other
Overweight prevention in pediatric primary care: a needs assessment of an urban racial/ethnic minority population.
PMID 19564448·Clin Pediatr (Phila)·2009
8-other
Computational principles of determining and improving mass precision and accuracy for proteome measurements in an Orbitrap.
PMID 19553133·J Am Soc Mass Spectrom·2009
8-other
Prevalence of transient hyperphosphatasemia among healthy infants and toddlers.
PMID 19620198·Pediatrics·2009
8-other
Commentary on statement on human papillomavirus test utilization.
PMID 19653706·Arch Pathol Lab Med·2009
8-other
Comparison of surface doses from spot scanning and passively scattered proton therapy beams.
PMID 19550003·Phys Med Biol·2009
4-observational
CarD tricks and magic spots: mechanisms of stringent control in mycobacteria.
PMID 19616759·Cell Host Microbe·2009
6-review
Long-term trends in use of and expenditures for cardiovascular medications in Canada.
PMID 19581604·CMAJ·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 110 METROPLEX BLVD STE H
PEARL, MS 39208 - Phone
- (601) 664-1664
Quick Facts
- NPI
- 1912572702
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile